{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:31:12Z","timestamp":1791419472696,"version":"4.3.3"},"reference-count":39,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2025,6,25]]},"DOI":"10.1253\/circj.cj-25-0092","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T22:13:04Z","timestamp":1748124784000},"page":"885-892","source":"Crossref","is-referenced-by-count":11,"title":["Phenotyping Heart Failure With Preserved Ejection Fraction Using Pulmonary Artery Pulsatility Index and Pulmonary Arterial Capacitance"],"prefix":"10.1253","volume":"89","author":[{"given":"Yuta","family":"Ozaki","sequence":"first","affiliation":[{"name":"Cardiovascular Center, Anjo Kosei Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Uemura","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Anjo Kosei Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Kazama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Anjo Kosei Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Okajima","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Anjo Kosei Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Mitsuda","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Anjo Kosei Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Anjo Kosei Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Takemoto","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Anjo Kosei Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Okumura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Watarai","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Anjo Kosei Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pieske B, Tschope C, de Boer RA, Fraser AG, Anker SD, Donal E, et al. How to diagnose heart failure with preserved ejection fraction: The HFA-PEFF diagnostic algorithm: A consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). <i>Eur Heart J<\/i> 2019; 40: 3297\u20133317.","DOI":"10.1093\/eurheartj\/ehz641"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Roh J, Hill JA, Singh A, Valero-Munoz M, Sam F. Heart failure with preserved ejection fraction: Heterogeneous syndrome, diverse preclinical models. <i>Circ Res<\/i> 2022; 130: 1906\u20131925.","DOI":"10.1161\/CIRCRESAHA.122.320257"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Guazzi M, Naeije R. Right heart phenotype in heart failure with preserved ejection fraction. <i>Circ Heart Fail<\/i> 2021; 14: e007840.","DOI":"10.1161\/CIRCHEARTFAILURE.120.007840"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nair N. Invasive hemodynamics in heart failure with preserved ejection fraction: Importance of detecting pulmonary vascular remodeling and right heart function. <i>Heart Fail Clin<\/i> 2021; 17: 415\u2013422.","DOI":"10.1016\/j.hfc.2021.03.003"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Borlaug BA, Sharma K, Shah SJ, Ho JE. Heart failure with preserved ejection fraction: JACC scientific statement. <i>J Am Coll Cardiol<\/i> 2023; 81: 1810\u20131834.","DOI":"10.1016\/j.jacc.2023.01.049"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Vonk Noordegraaf A, Westerhof BE, Westerhof N. The relationship between the right ventricle and its load in pulmonary hypertension. <i>J Am Coll Cardiol<\/i> 2017; 69: 236\u2013243.","DOI":"10.1016\/j.jacc.2016.10.047"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mohammed SF, Hussain I, AbouEzzeddine OF, Takahama H, Kwon SH, Forfia P, et al. Right ventricular function in heart failure with preserved ejection fraction: A community-based study. <i>Circulation<\/i> 2014; 130: 2310\u20132320.","DOI":"10.1161\/CIRCULATIONAHA.113.008461"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Padang R, Chandrashekar N, Indrabhinduwat M, Scott CG, Luis SA, Chandrasekaran K, et al. Aetiology and outcomes of severe right ventricular dysfunction. <i>Eur Heart J<\/i> 2020; 41: 1273\u20131282.","DOI":"10.1093\/eurheartj\/ehaa037"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Korabathina R, Heffernan KS, Paruchuri V, Patel AR, Mudd JO, Prutkin JM, et al. The pulmonary artery pulsatility index identifies severe right ventricular dysfunction in acute inferior myocardial infarction. <i>Catheter Cardiovasc Interv<\/i> 2012; 80: 593\u2013600.","DOI":"10.1002\/ccd.23309"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Javorski MJ, Bauza K, Xiang F, Soltesz E, Chen L, Bakaeen FG, et al. Identifying and mitigating risk of postcardiotomy cardiogenic shock in patients with ischemic and nonischemic cardiomyopathy. <i>J Thorac Cardiovasc Surg<\/i> 2024; 168: 1489\u20131499.","DOI":"10.1016\/j.jtcvs.2024.02.025"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kochav SM, Flores RJ, Truby LK, Topkara VK. Prognostic impact of pulmonary artery pulsatility index (PAPi) in patients with advanced heart failure: Insights from the ESCAPE trial. <i>J Card Fail<\/i> 2018; 24: 453\u2013459.","DOI":"10.1016\/j.cardfail.2018.03.008"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Morine KJ, Kiernan MS, Pham DT, Paruchuri V, Denofrio D, Kapur NK. Pulmonary artery pulsatility index is associated with right ventricular failure after left ventricular assist device surgery. <i>J Card Fail<\/i> 2016; 22: 110\u2013116.","DOI":"10.1016\/j.cardfail.2015.10.019"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nishimura T, Hirata Y, Ise T, Iwano H, Izutani H, Kinugawa K, et al. JCS\/JSCVS\/JCC\/CVIT 2023 guideline focused update on indication and operation of PCPS\/ECMO\/IMPELLA. <i>Circ J<\/i> 2024; 88: 1010\u20131046.","DOI":"10.1253\/circj.CJ-23-0698"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Koyun E, Sahin A. Mortality predictor in heart failure patients with preserved ejection fraction: Pulmonary artery pulsatility index. <i>Acta Cardiol<\/i> 2024; 79: 935\u2013941.","DOI":"10.1080\/00015385.2024.2406676"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Osama M, Ubaid S, Ullah U, Ubaid M. Pulmonary artery pulsatility index as a prognostic marker in heart failure with preserved ejection fraction. <i>Acta Cardiol<\/i> 2024, doi:10.1080\/00015385.2024.2412372.","DOI":"10.1080\/00015385.2024.2412372"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tedford RJ, Hassoun PM, Mathai SC, Girgis RE, Russell SD, Thiemann DR, et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. <i>Circulation<\/i> 2012; 125: 289\u2013297.","DOI":"10.1161\/CIRCULATIONAHA.111.051540"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Al-Naamani N, Preston IR, Paulus JK, Hill NS, Roberts KE. Pulmonary arterial capacitance is an important predictor of mortality in heart failure with a preserved ejection fraction. <i>JACC Heart Fail<\/i> 2015; 3: 467\u2013474.","DOI":"10.1016\/j.jchf.2015.01.013"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nakagawa A, Yasumura Y, Yoshida C, Okumura T, Tateishi J, Yoshida J, et al. Prognostic importance of pulmonary arterial capacitance in acute decompensated heart failure with preserved ejection fraction. <i>J Am Heart Assoc<\/i> 2021; 10: e023043.","DOI":"10.1161\/JAHA.121.023043"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Authors\/Task Force Members; McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. <i>Eur J Heart Fail<\/i> 2022; 24: 4\u2013131.","DOI":"10.1002\/ejhf.2333"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham study. <i>N Engl J Med<\/i> 1971; 285: 1441\u20131446.","DOI":"10.1056\/NEJM197112232852601"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus; Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Seino Y, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. <i>J Diabetes Investig<\/i> 2010; 1: 212\u2013228.","DOI":"10.1111\/j.2040-1124.2010.00074.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, et al. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. <i>N Engl J Med<\/i> 2019; 381: 1609\u20131620.","DOI":"10.1056\/NEJMoa1908655"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Bohm M, et al. Empagliflozin in heart failure with a preserved ejection fraction. <i>N Engl J Med<\/i> 2021; 385: 1451\u20131461.","DOI":"10.1056\/NEJMoa2107038"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. <i>Am J Kidney Dis<\/i> 2009; 53: 982\u2013992.","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. <i>J Am Soc Echocardiogr<\/i> 2005; 18: 1440\u20131463.","DOI":"10.1016\/j.echo.2005.10.005"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. <i>Eur Heart J<\/i> 2022; 43: 3618\u20133731.","DOI":"10.1093\/eurheartj\/ehac237"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Sartipy U, Dahlstrom U, Edner M, Lund LH. Predicting survival in heart failure: Validation of the MAGGIC heart failure risk score in 51,043 patients from the Swedish heart failure registry. <i>Eur J Heart Fail<\/i> 2014; 16: 173\u2013179.","DOI":"10.1111\/ejhf.32"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Rich JD, Burns J, Freed BH, Maurer MS, Burkhoff D, Shah SJ. Meta-Analysis Global Group in Chronic (MAGGIC) heart failure risk score: Validation of a simple tool for the prediction of morbidity and mortality in heart failure with preserved ejection fraction. <i>J Am Heart Assoc<\/i> 2018; 7: e009594.","DOI":"10.1161\/JAHA.118.009594"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Guazzi M, Dixon D, Labate V, Beussink-Nelson L, Bandera F, Cuttica MJ, et al. RV contractile function and its coupling to pulmonary circulation in heart failure with preserved ejection fraction: Stratification of clinical phenotypes and outcomes. <i>JACC Cardiovasc Imaging<\/i> 2017; 10: 1211\u20131221.","DOI":"10.1016\/j.jcmg.2016.12.024"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hashimoto T, Ikuta K, Yamamoto S, Yoshitake T, Suenaga T, Nakashima S, et al. Right ventricular to pulmonary artery uncoupling is associated with impaired exercise capacity in patients with transthyretin cardiac amyloidosis. <i>Circ J<\/i> 2024; 89: 31\u201340.","DOI":"10.1253\/circj.CJ-24-0402"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Reddy YNV, Obokata M, Verbrugge FH, Lin G, Borlaug BA. Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation. <i>J Am Coll Cardiol<\/i> 2020; 76: 1051\u20131064.","DOI":"10.1016\/j.jacc.2020.07.009"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Arvidsson S, Henein MY, Wikstrom G, Suhr OB, Lindqvist P. Right ventricular involvement in transthyretin amyloidosis. <i>Amyloid<\/i> 2018; 25: 160\u2013166.","DOI":"10.1080\/13506129.2018.1493989"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Pandey A, Shah SJ, Butler J, Kellogg DL Jr, Lewis GD, Forman DE, et al. Exercise intolerance in older adults with heart failure with preserved ejection fraction: JACC state-of-the-art review. <i>J Am Coll Cardiol<\/i> 2021; 78: 1166\u20131187.","DOI":"10.1016\/j.jacc.2021.07.014"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Vachiery JL, Delcroix M, Al-Hiti H, Efficace M, Hutyra M, Lack G, et al. Macitentan in pulmonary hypertension due to left ventricular dysfunction. <i>Eur Respir J<\/i> 2018; 51: 1701886.","DOI":"10.1183\/13993003.01886-2017"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Koller B, Steringer-Mascherbauer R, Ebner CH, Weber T, Ammer M, Eichinger J, et al. Pilot study of endothelin receptor blockade in heart failure with diastolic dysfunction and pulmonary hypertension (BADDHY-Trial). <i>Heart Lung Circ<\/i> 2017; 26: 433\u2013441.","DOI":"10.1016\/j.hlc.2016.09.004"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Biering-Sorensen T, Minamisawa M, Liu J, Claggett B, Papolos AI, Felker GM, et al. The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF). <i>Eur J Heart Fail<\/i> 2021; 23: 1052\u20131056.","DOI":"10.1002\/ejhf.2181"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Parkash R, Wells GA, Rouleau J, Talajic M, Essebag V, Skanes A, et al. Randomized ablation-based rhythm-control versus rate-control trial in patients with heart failure and atrial fibrillation: Results from the RAFT-AF trial. <i>Circulation<\/i> 2022; 145: 1693\u20131704.","DOI":"10.1161\/CIRCULATIONAHA.121.057095"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. <i>N Engl J Med<\/i> 2022; 387: 1089\u20131098.","DOI":"10.1056\/NEJMoa2206286"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS, et al. Finerenone in heart failure with mildly reduced or preserved ejection fraction. <i>N Engl J Med<\/i> 2024; 391: 1475\u20131485.","DOI":"10.1056\/NEJMoa2407107"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/7\/89_CJ-25-0092\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T03:16:13Z","timestamp":1751080573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/7\/89_CJ-25-0092\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-25-0092","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"article-number":"CJ-25-0092"}}